These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17270346

  • 1. Effects of desensitized nicotinic receptors on rotational behavior in a 6-hydroxydopamine model of Parkinson's disease.
    Han F, Wang H.
    Neurosci Lett; 2007 Mar 30; 415(3):200-4. PubMed ID: 17270346
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
    Yanagida T, Takeuchi H, Kitamura Y, Takata K, Minamino H, Shibaike T, Tsushima J, Kishimoto K, Yasui H, Taniguchi T, Shimohama S.
    Neurosci Res; 2008 Dec 30; 62(4):254-61. PubMed ID: 18845194
    [Abstract] [Full Text] [Related]

  • 3. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C, Jiménez A, Tolosa E, Bonastre M, Bové J.
    Synapse; 2004 Feb 30; 51(2):140-50. PubMed ID: 14618681
    [Abstract] [Full Text] [Related]

  • 4. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ.
    Exp Neurol; 2000 Jan 30; 161(1):212-9. PubMed ID: 10683287
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
    Glavan G, Zivin M.
    Neuroscience; 2005 Jan 30; 135(2):545-54. PubMed ID: 16111820
    [Abstract] [Full Text] [Related]

  • 6. 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
    Lebsanft HB, Kohles T, Kovar KA, Schmidt WJ.
    Synapse; 2005 Mar 01; 55(3):148-55. PubMed ID: 15602749
    [Abstract] [Full Text] [Related]

  • 7. Activities of cAMP-dependent protein kinase and protein kinase C are modulated by desensitized nicotinic receptors in the rat brain.
    Sun X, Liu Y, Hu G, Wang H.
    Neurosci Lett; 2004 Aug 26; 367(1):19-22. PubMed ID: 15308289
    [Abstract] [Full Text] [Related]

  • 8. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.
    Brain Res; 2006 Oct 30; 1117(1):18-24. PubMed ID: 16949560
    [Abstract] [Full Text] [Related]

  • 9. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.
    Delfino MA, Stefano AV, Ferrario JE, Taravini IR, Murer MG, Gershanik OS.
    Behav Brain Res; 2004 Jul 09; 152(2):297-306. PubMed ID: 15196797
    [Abstract] [Full Text] [Related]

  • 10. The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats.
    Rose S, Ramsay Croft N, Jenner P.
    Brain Res; 2007 Feb 16; 1133(1):110-4. PubMed ID: 17196564
    [Abstract] [Full Text] [Related]

  • 11. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M, Takata K, Yanagisawa D, Ashihara E, Tooyama I, Shimohama S, Kitamura Y.
    Neurochem Int; 2016 Mar 16; 94():74-81. PubMed ID: 26911419
    [Abstract] [Full Text] [Related]

  • 12. The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease.
    Silvestrin RB, de Oliveira LF, Batassini C, Oliveira A, e Souza TM.
    J Neurosci Methods; 2009 Mar 15; 177(2):317-21. PubMed ID: 19026686
    [Abstract] [Full Text] [Related]

  • 13. [Modulation by desensitized nicotinic receptors on metabolism of DA in striatum derived from the hemiparkinsonian model].
    Fu-Rong H, Hai W.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jun 08; 32(6):487-493. PubMed ID: 29926613
    [Abstract] [Full Text] [Related]

  • 14. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA, Tse A, Ballermann M, Smith LK, Fouad K.
    Eur J Neurosci; 2005 Aug 08; 22(3):735-44. PubMed ID: 16101755
    [Abstract] [Full Text] [Related]

  • 15. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N, Di Chiara G, Daniels WM, Schallert T, Morelli M.
    Neuroscience; 2009 Feb 18; 158(4):1625-31. PubMed ID: 19063947
    [Abstract] [Full Text] [Related]

  • 16. Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.
    Bordia T, McGregor M, McIntosh JM, Drenan RM, Quik M.
    Neuroscience; 2015 Jun 04; 295():187-97. PubMed ID: 25813704
    [Abstract] [Full Text] [Related]

  • 17. Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.
    Löschmann PA, De Groote C, Smith L, Wüllner U, Fischer G, Kemp JA, Jenner P, Klockgether T.
    Exp Neurol; 2004 May 04; 187(1):86-93. PubMed ID: 15081591
    [Abstract] [Full Text] [Related]

  • 18. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.
    J Neurosci Res; 2009 Feb 04; 87(2):576-85. PubMed ID: 18803299
    [Abstract] [Full Text] [Related]

  • 19. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T, Noda T, Satomi M, Ohtaki K, Chiba K, Tasaki Y, Shiono H.
    Brain Res; 2006 Sep 27; 1112(1):126-33. PubMed ID: 16884702
    [Abstract] [Full Text] [Related]

  • 20. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?
    Konitsiotis S, Tsironis C.
    Behav Brain Res; 2006 Jun 30; 170(2):337-41. PubMed ID: 16621050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.